(Report ID: 51032) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,590 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 1,093 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 51032 | Feb, 22, 2006 | 35 | Female |
List of drugs the patient takes:
| Drug |
Stavudine |
Lamivudine |
Bactrim |
| Name |
Anion Gap Increased |
Blood Lactic Acid Increased |
Weight Increased |
Results from eHealthMe: 1,093 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Anion Gap Increased | 7 (0.64%) |
Blood Lactic Acid Increased | 45 (4.12%) |
Weight Increased | 15 (1.37%) |
Death: 1 (7.69% of total reports)
Cancer: 0
| Name | Count (% of total reports) |
1 | Hyperlipidaemia | 4 (30.77%) |
2 | Immune Reconstitution Syndrome | 3 (23.08%) |
3 | Mycobacterium Avium Complex Immune Restoration Disease | 2 (15.38%) |
4 | Cytomegalovirus Viraemia | 2 (15.38%) |
5 | Nutritional Condition Abnormal | 2 (15.38%) |
6 | Dandy-walker Syndrome | 2 (15.38%) |
7 | Optic Neuritis Retrobulbar | 2 (15.38%) |
8 | White Blood Cell Count Decreased | 2 (15.38%) |
9 | Blood Alkaline Phosphatase Increased | 2 (15.38%) |
10 | Hyperlactacidaemia | 2 (15.38%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Ganciclovir | 12 |
2 | Kaletra | 11 |
3 | Norvir | 10 |
4 | Foscarnet Sodium | 8 |
5 | Sodium Chloride 0.9% | 8 |
6 | Ethambutol Hcl | 8 |
7 | Viread | 8 |
8 | Valganciclovir Hcl | 7 |
9 | Zidovudine | 7 |
10 | Zerit | 7 |
Death: 10 (0.91% of total reports)
Cancer: 8 (0.73% of total reports)
| Name | Count (% of total reports) |
1 | Pyrexia | 121 (11.07%) |
2 | Nausea | 111 (10.16%) |
3 | Lactic Acidosis | 95 (8.69%) |
4 | Vomiting Nos | 65 (5.95%) |
5 | Hypertriglyceridaemia | 63 (5.76%) |
6 | Abdominal Pain Nos | 60 (5.49%) |
7 | Blood Triglycerides Increased | 51 (4.67%) |
8 | Anaemia | 51 (4.67%) |
9 | Weight Decreased | 50 (4.57%) |
10 | Condition Aggravated | 49 (4.48%) |
| Name | Count |
1 | Epivir | 929 |
2 | Zerit | 778 |
3 | Crixivan | 218 |
4 | Kaletra | 215 |
5 | Viracept | 209 |
6 | Norvir | 188 |
7 | Retrovir | 185 |
8 | Cotrim | 147 |
9 | Viramune | 132 |
10 | Videx | 129 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
